Synapse

← Neuroprotection/Neuroprotection (Chichester, England. Print)

Papers in Neuroprotection/Neuroprotection (Chichester, England. Print)

Page 2 · newest first

  1. History of pre‐eclampsia negatively impacts stroke severity postpartum in ratsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  2. The role of gut microbiota‐derived metabolites in neuroinflammationNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  3. Targeting gut microbiota as a therapeutic approach for neurodegenerative diseasesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  4. Unravelling the nexus of stroke and dementia: Deciphering the role of secondary neurodegeneration in orchestrating cognitive declineNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  5. Downregulation of forkhead box O1 (FOXO1) acetylation ameliorates cognitive dysfunction by inhibiting endoplasmic reticulum stress‐regulated neuronal apoptosis in APP/PS1 transgenic miceNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  6. Advancing neuroprotection and atherosclerosis prevention through familial hypercholesterolemia management: Analyzing comorbidity burden with stroke, coronary heart disease, hypertension, and diabetesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  7. The dynamic relationship of brain‐derived neurotrophic factor and oxytocin: Introducing the concept of neurosocial plasticityNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  8. Oral microbiota and central nervous system diseases: A reviewNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  9. Stroke and associated comorbidities in Southeast Asian countriesSHILAP Revista de lepidopterología · 2025
  10. Decoding the role of large heat shock proteins in the progression of neuroinflammation‐mediated neurodegenerative disordersNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  11. Pilot functional magnetic resonance imaging study of clemastine‐aided functional recovery on a mouse model of demyelinationNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  12. Liver enzyme and risk of vascular dementia: A univariable and multivariable Mendelian randomization of European descentNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  13. Neurodegeneration in acute and chronic central nervous system disorders: Novel ideas and approachesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  14. A multicenter single‐arm objective performance criteria trial evaluating the efficacy and safety of a dedicated venous sinus thrombectomy device for severe cerebral venous sinus thrombosisNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  15. Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticlesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  16. Rodent ischemic stroke models and their relevance in preclinical researchNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  17. A novel perspective in stroke neuroprotection: Leveraging hypoxic pocket insights for studying preconditioning and postconditioningNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  18. Mass spectrometry‐based proteomics for biomarker discovery in the Drosophila model of Parkinson's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  19. Blood‐based biomarkers of Alzheimer's disease: Standardization and comprehensivenessNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  20. Impact of neutrophil‐to‐lymphocyte ratio on the effect of hyperglycemia at admission on clinical outcomes after endovascular thrombectomyNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  21. Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunitiesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  22. Interleukin‐6 induces cognitive impairment via toll‐like receptor 4 (TLR4)‐mediated neuroinflammation and neurodegeneration in mice with chronic kidney diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  23. Five percent CO₂ inhalation alleviates hippocampal glutamate and water homeostasis disturbance, neuronal damage, and learning‐memory impairment in sleep‐deprived ratsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  24. Tolerability and first hints for potential efficacy of motor‐cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpointNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  25. Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotectionNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  26. Stress enhances expression of calcium‐binding proteins and NMDAR subunit genes in the rat hippocampusNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  27. The role of angiotensin II type 1 receptor pathway in cerebral ischemia‒reperfusion injury: Implications for the neuroprotective effect of ARBsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  28. Novel therapeutic strategies and common mechanisms of neurodegenerative diseasesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  29. Role of gut microbiota in ischemic stroke: A narrative review of human and animal studiesSHILAP Revista de lepidopterología · 2024
  30. Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A reviewNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  31. Research progress on intranasal treatment for Parkinson's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  32. Beyond boundaries: Neuroprotective effects of steroids and ecdysteroids in SH‐SY5Y cells ‐ A systematic reviewNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  33. The dual role of microglia in ischemic stroke and its modulation via extracellular vesicles and stem cellsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  34. Neuroprotective effects of repetitive transcranial magnetic stimulation on Alzheimer's disease: Undetermined therapeutic protocols and mechanismsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  35. Mitigating the impact of mechanisms causing neuronal degenerationNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  36. Role of autoreactive Tc17 cells in the pathogenesis of experimental autoimmune encephalomyelitisNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  37. Mechanisms of glutamate metabolic function and dysfunction in vascular dementiaNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  38. Intracranial pressure is elevated at 24 h post‐stroke in miceNeuroprotection/Neuroprotection (Chichester, England. Print) · 2024
  39. The potential of a combined cell‐based therapy and rehabilitation approach for stroke recoveryNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  40. Mesenchymal stem cell‐derived exosomes: Shaping the next era of stroke treatmentNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  41. Mononuclear cell therapy of neonatal hypoxic‐ischemic encephalopathy in preclinical versus clinical studies: A systematic analysis of therapeutic efficacy and study designNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  42. Activation of dopamine 2 receptors modulates glutamate decarboxylases 65 and 67 during stroke recovery in miceNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  43. Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated reviewNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  44. Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)SHILAP Revista de lepidopterología · 2023
  45. Monocytes in neonatal stroke and hypoxic‐ischemic encephalopathy: Pathophysiological mechanisms and therapeutic possibilitiesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  46. Liquid–liquid phase separation in synaptopathiesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  47. 3D printing‐based frugal manufacturing of glass pipettes for minimally invasive delivery of therapeutics to the brainNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  48. Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progressNeuroprotection/Neuroprotection (Chichester, England. Print) · 2023
  49. Ex vivo 100 μm isotropic diffusion MRI‐based tractography of connectivity changes in the end‐stage R6/2 mouse model of Huntington's diseaseSHILAP Revista de lepidopterología · 2022
  50. Aspects of xenobiotics and their receptors in strokeNeuroprotection/Neuroprotection (Chichester, England. Print) · 2022